Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

Conditions: Pancreatic Adenocarcinoma; Liver Metastases
Interventions: Drug: Floxuridine (FUDR); Device: Hepatic Artery Infusion Pump; Drug: Heparinized Saline
Sponsors: Spectrum Health Hospitals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 9, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments